Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
ProPhase Labs Inc. logo

ProPhase Labs Inc.

Sector: Healthcare   

Industry: Drug Manufacturers - Major

5.09
 
USD
  
0.29
  
(6.04%)
Optionable: Yes  Market Cap: 87 M  90-day average vol: 25,660

Previous close: 4.8  Open: 5.01  Bid: 4.8  Ask: 5.2
52 week range    
4.05   
   10.86
Peers   
MTEX / 
RELV / 
USNA / 
NATR / 
OGEN / 
CYAN / 
Last updated: Friday 8th December 2023
60
MarketXLS Rank
40
Value
69
Technical
71
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

CYAN

0 B8.52.89

MTEX

0.02240 B8.735.7099

NATR

0 B16.817.8

OGEN

0 B-2.50.4344

RELV

USNA

2 B14.693.09

XOMA

0 B138.120.07
Financials

PRPH Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
Amortization974000.06 M-2 M
Amortization of intangibles901000.06 M-2 M
Basic EPS from continuing operations0.04-0.47-0.22-0.24-0.14-0.14-0.54-0.380.82
Basic EPS total0.03-0.47-0.22-0.172.61-0.15-0.54-0.360.821.17
Basic weighted shares outstanding16 M16773.016 M17081.016 M11 M12 M12 M15 M16 M
BasicDiscontinuousOperations0.072.75-0.010.02
Cost of sales-8 M-8 M-8 M-3 M-8 M-8 M7 M10 M37 M-52 M
Depreciation-243000.0-277000.0-367000.0-426000.0-337000.0-383000.0-398000.0375000.02 M-2 M
Depreciation unreconciled-5 M
DepreciationAndAmortization-243000.0-277000.0-367000.0-426000.0-337000.0-383000.0-398000.0375000.02 M-5 M
DevelopmentExpense-300000.0-300000.0
Diluted EPS total0.03-0.47-0.22-0.172.59-0.15-0.54-0.360.81.02
Diluted normalized net income/share0.03-0.47-0.22-0.24-0.14-0.14-0.270.8
Diluted weighted shares outstanding16 M16773.016 M17081.016 M12 M12 M18 M19 M
DilutedDiscontinuousOperations0.072.73-0.01
Fees2000.0
GainOnSaleOfPPE2 M
GainOnSaleOfSecurity54000.022000.04000.0-240000.0856000.0
GainsLossOnDisposalOfDiscontinuedOperations1 M43 M-340000.0-40000.0201000.0
GeneralAndAdministrativeExpense6 M8 M7 M3 M5 M5 M4 M7 M22 M34 M
Gross operating profit17 M14 M12 M997000.02 M5 M3 M5 M42 M71 M
ImpairmentOfCapitalAssets-4 M
Income before tax405000.0-8 M-4 M-4 M-4 M-1 M-3 M-2 M5 M23 M
Income restructuring and M&A-228000.0-2 M-6 M-6 M
Income taxes-1 M3 M1 M1 M-1 M103000.07000.012000.0-968000.04 M
Interest income2000.04000.02000.01000.0177000.0167000.0133000.062000.0642000.0153000.0
InterestExpenseNonOperating13000.010000.018000.0213000.054000.0295000.01 M764000.0
InterestIncomeOperating62000.0642000.0
MarketingExpense-11 M-11 M-8 M-10 M-264000.0-443000.0
MiscOtherSpecialCharges187000.0150000.0
Net income from total operations405000.0-8 M-4 M-3 M41 M-2 M-3 M-2 M6 M19 M
NetIncomeCommonStockholders405000.0-8 M-4 M-3 M41 M-2 M-3 M-1 M28 M19 M
NetIncomeContinuousOperations405000.0-8 M-4 M-3 M41 M-2 M-3 M-2 M6 M19 M
NetIncomeDiscontinuousOperations1 M43 M-340000.0-40000.0201000.0
NetNonOperatingInterestIncomeExpense-11000.0-6000.0-16000.0-212000.0177000.0167000.0133000.0-233000.0-506000.0-611000.0
NonRecurringOperationExpense-13000.0-10000.0
Normalized income4 M
Operating income416000.0-4 M-4 M-4 M-4 M-2 M-3 M-2 M10 M24 M
Operating income before depreciation (EBITDA)661000.0-8 M-3 M-3 M-3 M-1 M-3 M-2 M10 M29 M
OperatingExpense-16 M-22 M-16 M-5 M-6 M-6 M6 M9 M32 M-47 M
Other income net4 M-187000.0-150000.0-54000.0-22000.0-2 M404000.0-856000.0
OtherGainLossFromDispositionOfDiscontinuedOperations201000.0
OtherGandA6 M8 M7 M3 M5 M5 M4 M7 M22 M34 M
OtherImpairmentOfCapitalAssets4 M
OtherOperatingExpenses-152000.0-448000.0-9 M12 M
OtherWriteOff-5 M
RentAndLandingFees6 M8 M7 M3 M5 M5 M34 M
Research & development expense824000.01 M1 M358000.0431000.0398000.0332000.0633000.0500000.0700000.0
ResearchExpense824000.01 M1 M358000.0431000.0398000.0332000.0633000.0500000.0700000.0
RestructringAndMnAIncome-228000.0-2 M-6 M-6 M
SalariesAndWages-269000.0-1000000.0-135000.0-1000.0-78000.0-590000.0-744000.01 M-4 M
Selling Gen & administrative expense15 M17 M15 M4 M6 M6 M6 M7 M22 M34 M
SellingAndMarketingExpense10 M9 M8 M2 M699000.01 M1 M1 M
SellingExpense10 M9 M8 M2 M699000.01 M1 M
Special income/charges13000.04 M228000.02 M6 M6 M
Total Income available for interest expense (EBIT)418000.0-8 M-4 M-4 M-4 M-1 M-3 M-2 M6 M24 M
Total common shares outstanding17 M16 M17 M17 M11 M12 M12 M15 M15 M17 M
Total net income405000.0-8 M-4 M-3 M41 M-2 M-3 M-2 M6 M19 M
Total ordinary shares18 M18 M18 M18 M18 M18 M18 M18 M18 M18 M
Total revenues25 M22 M21 M4 M10 M13 M10 M15 M79 M123 M
TotalExpenses-25 M-30 M-24 M-8 M-14 M-15 M13 M18 M69 M-99 M
TotalRevenue25 M22 M21 M4 M10 M13 M10 M15 M79 M123 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder/CEO of MarketXLS. With over six years of experience, I've helped 2500+ customers implement personalized investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.
Get started today